Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 5.3.2.1 extracted from

  • Garai, J.; Molnar, V.; Eros, D.; Orfi, L.; Lorand, T.
    MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones (2007), Int. Immunopharmacol., 7, 1741-1746.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
(2Z)-2-(2-methoxybenzylidene)cyclopentanone
-
Bos taurus
(2Z)-2-(4-bromobenzylidene)cyclopentanone
-
Bos taurus
(2Z)-2-(4-methoxybenzylidene)cyclohexanone
-
Bos taurus
(2Z)-2-(4-methoxybenzylidene)cyclopentanone
-
Bos taurus
(2Z)-2-(pyridin-2-ylmethylene)-3,4-dihydronaphthalen-1(2H)-one
-
Bos taurus
(2Z)-2-benzylidenecyclopentanone
-
Bos taurus
(2Z,5Z)-2,5-dibenzylidenecyclopentanone
-
Bos taurus

Organism

Organism UniProt Comment Textmining
Bos taurus
-
-
-

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.00079
-
-
Bos taurus (2Z)-2-(4-bromobenzylidene)cyclopentanone
0.0016
-
-
Bos taurus (2Z,5Z)-2,5-dibenzylidenecyclopentanone
0.0025
-
-
Bos taurus (2Z)-2-(2-methoxybenzylidene)cyclopentanone
0.0031
-
-
Bos taurus (2Z)-2-(4-methoxybenzylidene)cyclohexanone
0.0039
-
-
Bos taurus (2Z)-2-(4-methoxybenzylidene)cyclopentanone
0.0056
-
-
Bos taurus (2Z)-2-(pyridin-2-ylmethylene)-3,4-dihydronaphthalen-1(2H)-one
0.0062
-
22°C, pH 6.5 Bos taurus (2Z)-2-benzylidenecyclopentanone